Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol combined with alfentanil or remifentanil for general anesthesia in laryngeal microsurgery
ChiCTR2100054186Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Jan 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol, alfentanil and remifentanil in laryngeal polyp (4 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoint: Hemodynamics. Started Jan 2022; status: recruiting.
02
Drugs
propofolalfentanilremifentanil
03
Conditions
laryngeal polyp
Beyond the preview
Go deeper on ChiCTR2100054186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054186.